Increase in circulating Th17 cells during anti-TNF therapy is associated with ultrasonographic improvement of synovitis in rheumatoid arthritis.

Arthritis Res Ther · 2016 · PMC5180397 · PMID 28010726

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Anti-TNF non-responders showed a trend towards having a higher frequency of circulating Th17 cells at baseline compared to good responders, both by Elispot (EULAR non-responders vs good responders median (range) spSFC/10 6 , 538 (280–725) vs 405 (310–540), p value not significant) and FACS (EULAR non-responders vs good responders median (range) %, 0.9 (0.7–1.2) vs 0.7 (0.48–0.9), p value not significant).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.